FXOpen
Promotion: Yes
Regulated By: ASIC - AFSL 412871, FCA - 579202
Headquarters: Auckland, New ZealandLevel 3, 187 Queen Street, Cbd,Auckland, 1010New ZealandPhone:+64 9 801 0123
Foundation Year: 2005
-
Visit WebsiteWebsite
-
sales@fxopen.comSkype
-
+7 (495) 646-38-24FAX
-
sales@fxopen.comEmail
-
+64 9 801 0123Telephone
Trading Info
$1
1:500
0.0 Pips
Yes
Yes
Yes
Yes
MetaTrader 4 (MT4)
Accounting Info
Yes
Bank Wire Transfer, Netbanx, Local Bank Transfers, China Union Pay, Credit/Debit Cards, WebMoney, Neteller, Skrill, QIWI Wallet, Perfect Money, Payza, SorexPay, Yandex Money, FasaPay, IntellectMoney, Wallet One, Bitcoin, Litecoin, Namecoin, RBK Money, De
Bank Wire Transfer, Netbanx, Local Bank Transfers, China Union Pay, Credit/Debit Cards, WebMoney, Neteller, Skrill, QIWI Wallet, Perfect Money, Payza, SorexPay, Yandex Money, FasaPay, IntellectMoney, Wallet One, Bitcoin, Litecoin, Namecoin, RBK Money, De
Yes
Yes
Yes
Yes
Yes
Yes
Contact Info
FXOpen
New Zealand
GBP,EUR or More
Arabic, Chinese, German, Indonesian, Malay, Portuguese, Russian, Spanish
ECN
Broker Info
Reviews (2)
Add Your review

Best MT4 Broker
with lowest cost
with lowest cost
Exclusive Access to
PRO Trader Tools
PRO Trader Tools
Free Trading
Signals
Signals
50% Cashback
Bonus New
Bonus New
Follow 6k+ Pro Traders
with CopyTrader
with CopyTrader
Jerdoroth
Tuesday 01st of October 2024 12:41 AM
In assessing this level of familiarity, the trial judge should focus on the nature of the relationship between the potential witness and the accused, including the frequency and intensity of past contact generic priligy online 2018; Vattulainen Collanus et al
eluborb
Saturday 29th of July 2023 11:59 AM
What s truly close to his heart is Paul s desire to encourage other transgender people to be wise about their health finasteride tablets for sale In order to overcome the limitation of exome sequencing, which had low sequence coverage, we attempted to PCR amplify 57 regions of the genomic DNA products from the above study, including the 5 target regions and 52 off target sites primers and expected amplicon sequences listed in Figures S10 and S11